MedCap AB Stock price
AI Insights on MedCap AB
Insights
Is MedCap AB a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?
As a Free StocksGuide user, you can view scores for all 9,120 stocks worldwide.
Key metrics
MedCap AB Stock Analysis
Analyst Opinions
7 Analysts have issued a MedCap AB forecast:
Analyst Opinions
7 Analysts have issued a MedCap AB forecast:
Don't miss a Thing! We will send you all news about MedCap AB directly to your mailbox free of charge.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Company Profile
MedCap AB is an investment company engaged in biotechnology and medical technology capital investments. The company is headquartered in Stockholm, Stockholm and currently employs 583 full-time employees. The company went IPO on 2006-07-04. The firm reports four segments: Abilia, Unimedic, Quickels and Inpac. The Company’s portfolio includes such companies as Abilia AB, which is engaged in the development and marketing of aids within the fields of communication, cognition, noise and environmental control; Unimedic AB, engaged in contract manufacturing of liquid pharmaceuticals; Quickels Systems AB, which is engaged in the development and marketing of intensive medical care equipment, such as care bags and electrocardiogram (ECG) equipment; AirContainer Package System AB that offers a wide range of packaging solutions for the pharmaceutical industry, and Dunmedic AB, which offers medical products, medicines and food supplements.
| Head office | Sweden |
| CEO | Mr. Dahlberg |
| Employees | 637 |
| Website | www.medcap.se |


